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Massive pulmonary hemorrhage can pose a signiﬁcant therapeutic challenge. Traditional methods of
airway clearance using saline lavage and direct thrombus removal via bronchoscopy have limited ability
to retrieve thrombi from deep airways. We report a patient on extracorporeal life support with massive
pulmonary hemorrhage resulting in extensive alveolar and airway thrombus extending well beyond the
proximal airways and the novel use of perﬂuorodecalin lavage to facilitate airway clearance and lung
recruitment.
Clinical trial registration: None.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Conventional approaches to treating pulmonary hemorrhage
rely on sustained positive pressure ventilation to tamponade
bleeding, with eventual expectoration and absorption of coagu-
lated blood once the acute hemorrhage has resolved. In cases of
severe pulmonary hemorrhage with signiﬁcant compromise of
oxygenation and ventilation, extracorporeal life support (ECLS) can
be used to provide time for lung recovery. This therapy is compli-
cated, however, by the need for anticoagulation. After bleeding has
stopped, bronchoscopy is the primary therapeutic option for
reopening obstructed airways, though its utility is largely limited to
the proximal airways, where suction and biopsy forceps can be
used to manually retrieve clot [1,2]. We describe the use of per-
ﬂuorodecalin (PFD) lavage to facilitate airway clearance and lung
recruitment in the setting of pulmonary hemorrhage.
Case
A previously healthy 17 year-old female presented with a 5 day
history of fevers, chills, cough, myalgia and shortness of breath. SheMedicine, 3434 Fifth Avenue,
: þ1 412 383 1080.
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Ltd. This is an open access article uwas treated for community-acquired pneumonia but had sub-
stantial increase in her oxygen requirements resulting in transfer to
the PICU andmechanical ventilation. Placement of a pigtail catheter
for pneumothorax was complicated by the development of hemo-
thorax, pulmonary hemorrhage and marked hemodynamic insta-
bility. On hospital day #10 she was placed on veno-arterial ECLS.
Chest CT demonstrated ﬂuid-ﬁlled airways with complete opa-
ciﬁcation of both lungs and bronchoscopy revealed thrombus
occluding both mainstem bronchi. Sequential attempts at saline
lavage to clear these thrombi were minimally successful. The pa-
tient's inability to wean from ECLS in the setting of her lung disease
prompted the care team to explore less conventional modalities of
pulmonary lavage. PFD (OriGen Biomedical, Inc, Austin, TX, USA)was
obtained on a compassionate use basis and several aliquots were
used to lavage the distal airways of the left lung. Subsequently, the
patient was able to cough up some clot debris. Based on the relative
success of these small-volume lavages, 250 mL, or approximately
4 mL/kg of PFD was gradually introduced to the left lung over
approximately 4 h under bagged pressures of 20/10 mmHg. The
patient was then placed onpressure control mechanical ventilation,
20/10 mmHg, overnight. Repeat bronchoscopy the following day
demonstrated soft thrombus in the main trachea just distal to the
endotracheal tube that had apparently been softened and buoyed
up by the PFD. Clot was removed over approximately 4 h with
simple suctioning until only clear liquid could be aspirated. A short
period of high-frequency oscillatory ventilation was used to opti-
mize recruitment, with the subsequent chest xray demonstrating
signiﬁcant recruitment of the bilateral upper lobes and left lowernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Chest X-rays obtained prior to pulmonary lavage with PFD (A) and following suctioning of PFD, thrombus and approximately 24 h of recruitment with high-frequency
oscillatory ventilation (B). There is interval improvement in aeration and new air bronchograms consistent with clot removal. PFD, perﬂuorodecalin.
C.M. Horvat et al. / Respiratory Medicine Case Reports 15 (2015) 7e88lobe far beyond the extent to which bronchoscopy can visualize
(Fig. 1). The patient's primary disease process prevented further
weaning from ECLS and she eventually received a double lung
transplant, with the explanted lung revealing extensive necrosis
and pneumonia attributed to Staphylococcus aureus.
Discussion
Perﬂuorocarbons have been examined for a variety of potential
pulmonary applications, including tidal liquid ventilation, partial
liquid ventilation, and as lavage solutions [3,4]. PFD also holds
unique potential in airway lavage and alveolar recruitment in the
setting of pulmonary hemorrhage. The density of human clot has
been reported as (1.08 ± 0.02) x103 kg/m3, which is slightly greater
than aqueous 0.9% NaCl, which has a density of 1.00  103 kg/m3 at
37 C [5,6]. In contrast, the density of PFD is 1.93  103 kg/m3,
allowing it to buoy thrombus to the proximal airways where it can
be retrieved via bronchoscopy [7]. Alveolar surface phospholipids
are inhibited by the presence of ﬁbrin, thereby raising the surface
tension and promoting alveolar derecruitment [8]. The addition of
small volumes of liquid ﬂuorocarbon has been shown to signiﬁ-
cantly decrease the magnitude of pressure required to recruit
alveoli [9,10]. This impact is theorized to stem from the positive
spreading coefﬁcient of liquid ﬂuorocarbons relative to surfactant,
particularly at the alveolar septal crests [10,11].
Once sufﬁcient lung function has recovered, PFD can be
removed via direct suction or allowed to passively evaporate. Sys-
temic absorption of PFD has not been reported, though patients
treated with perﬂurbron, a comparable liquid ﬂuorocarbon,
demonstrate small but quantiﬁable serum levels of the substance
following instillation in the lungs [12]. While promising for acute
therapies, it must be noted that robust long-term data on the effects
of perﬂuorocarbon lavage and ventilation do not exist, though
existing case reports of patients evaluated 9e12 years following
treatment make no mention of any detrimental impact [13,14]. The
use of PFD lavage in this case demonstrates the potential utility of
this unique medium for concomitant ventilation and lavage in pa-
tients suffering from severe pulmonary hemorrhage with distal
airway obstruction resulting from in situ thrombus.
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